Morepen Laboratories Ltd Half Yearly Results

Gross Sales

918.63

892.94

867.63

822.8

712.15

Excise Duty

0

0

0

0

0

Net Sales

918.63

892.94

867.63

822.8

712.15

Other Operating Income

0

0

0

0

0

Other Income

9.95

8.42

8.31

5.66

4.35

Total Income

928.58

901.36

875.94

828.46

716.5

Total Expenditure

840.25

797.25

768.68

763.13

676.07

PBIDT

88.33

104.1

107.26

65.34

40.42

Interest

6.01

2.33

2.97

0.74

1.11

PBDT

82.32

101.77

104.29

64.59

39.31

Depreciation

21.4

7.58

18.07

15.4

14.17

Minority Interest Before NP

0

0

0

0

0

Tax

9.19

23.17

25.93

13.3

7.7

Deferred Tax

4.73

0

-0.44

0

0.2

Reported Profit After Tax

47

71.02

60.73

35.89

17.23

Minority Interest After NP

-0.01

0

0.46

0

0

Net Profit after Minority Interest

47

71.02

60.27

35.89

17.23

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

47

71.02

60.27

35.89

17.23

EPS (Unit Curr.)

0.86

1.36

1.18

0.71

0.34

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

0

Equity

109.58

109.58

102.23

102.23

102.23

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

9.61

11.65

12.36

7.94

5.67

PBDTM(%)

-

-

-

-

-

PATM(%)

5.11

7.95

6.99

4.36

2.41